nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—brown adipose tissue—hypothyroidism	0.0666	0.168	CbGeAlD
Pentoxifylline—NT5E—Differentiation Pathway—TPO—hypothyroidism	0.0212	0.174	CbGpPWpGaD
Pentoxifylline—ADORA1—nerve—hypothyroidism	0.0179	0.0451	CbGeAlD
Pentoxifylline—Abdominal bloating—Liotrix—hypothyroidism	0.0177	0.0367	CcSEcCtD
Pentoxifylline—Angina pectoris—Liothyronine—hypothyroidism	0.0142	0.0296	CcSEcCtD
Pentoxifylline—CYP1A2—urine—hypothyroidism	0.0118	0.0297	CbGeAlD
Pentoxifylline—NT5E—heart—hypothyroidism	0.0108	0.0272	CbGeAlD
Pentoxifylline—Arrhythmia—Liothyronine—hypothyroidism	0.0104	0.0217	CcSEcCtD
Pentoxifylline—NT5E—cardiovascular system—hypothyroidism	0.0102	0.0257	CbGeAlD
Pentoxifylline—NT5E—gonad—hypothyroidism	0.00925	0.0233	CbGeAlD
Pentoxifylline—NT5E—pituitary gland—hypothyroidism	0.00903	0.0227	CbGeAlD
Pentoxifylline—Hypertension—Liothyronine—hypothyroidism	0.00879	0.0183	CcSEcCtD
Pentoxifylline—ADORA2A—Monoamine Transport—SLC5A7—hypothyroidism	0.00842	0.0693	CbGpPWpGaD
Pentoxifylline—PDE4A—heart—hypothyroidism	0.00825	0.0208	CbGeAlD
Pentoxifylline—Tachycardia—Liothyronine—hypothyroidism	0.00811	0.0168	CcSEcCtD
Pentoxifylline—NT5E—adrenal gland—hypothyroidism	0.00807	0.0203	CbGeAlD
Pentoxifylline—NT5E—blood—hypothyroidism	0.00806	0.0203	CbGeAlD
Pentoxifylline—NT5E—thyroid gland—hypothyroidism	0.00778	0.0196	CbGeAlD
Pentoxifylline—Hypotension—Liothyronine—hypothyroidism	0.00776	0.0161	CcSEcCtD
Pentoxifylline—ADORA2B—pituitary gland—hypothyroidism	0.00773	0.0195	CbGeAlD
Pentoxifylline—Lightheadedness—Liotrix—hypothyroidism	0.00753	0.0156	CcSEcCtD
Pentoxifylline—NT5E—female gonad—hypothyroidism	0.00752	0.0189	CbGeAlD
Pentoxifylline—ADORA2A—cardiovascular system—hypothyroidism	0.00727	0.0183	CbGeAlD
Pentoxifylline—PDE5A—heart—hypothyroidism	0.00701	0.0177	CbGeAlD
Pentoxifylline—Angina pectoris—Levothyroxine—hypothyroidism	0.00699	0.0145	CcSEcCtD
Pentoxifylline—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00699	0.0145	CcSEcCtD
Pentoxifylline—Swelling—Liotrix—hypothyroidism	0.00692	0.0144	CcSEcCtD
Pentoxifylline—ADORA2B—blood—hypothyroidism	0.0069	0.0174	CbGeAlD
Pentoxifylline—NT5E—testis—hypothyroidism	0.00667	0.0168	CbGeAlD
Pentoxifylline—ADORA1—heart—hypothyroidism	0.00665	0.0167	CbGeAlD
Pentoxifylline—PDE5A—cardiovascular system—hypothyroidism	0.00662	0.0167	CbGeAlD
Pentoxifylline—ADORA2A—gonad—hypothyroidism	0.00659	0.0166	CbGeAlD
Pentoxifylline—Body temperature increased—Liothyronine—hypothyroidism	0.00657	0.0136	CcSEcCtD
Pentoxifylline—NT5E—liver—hypothyroidism	0.00631	0.0159	CbGeAlD
Pentoxifylline—ADORA1—cardiovascular system—hypothyroidism	0.00627	0.0158	CbGeAlD
Pentoxifylline—PDE4A—adrenal gland—hypothyroidism	0.00616	0.0155	CbGeAlD
Pentoxifylline—Sweating—Dextrothyroxine—hypothyroidism	0.00613	0.0127	CcSEcCtD
Pentoxifylline—Sweating—Levothyroxine—hypothyroidism	0.00613	0.0127	CcSEcCtD
Pentoxifylline—PDE5A—gonad—hypothyroidism	0.00601	0.0151	CbGeAlD
Pentoxifylline—PDE4A—thyroid gland—hypothyroidism	0.00594	0.015	CbGeAlD
Pentoxifylline—ADORA2A—adrenal gland—hypothyroidism	0.00575	0.0145	CbGeAlD
Pentoxifylline—ADORA2A—blood—hypothyroidism	0.00575	0.0145	CbGeAlD
Pentoxifylline—PDE4A—female gonad—hypothyroidism	0.00574	0.0145	CbGeAlD
Pentoxifylline—ADORA2B—testis—hypothyroidism	0.00571	0.0144	CbGeAlD
Pentoxifylline—Flushing—Dextrothyroxine—hypothyroidism	0.00533	0.0111	CcSEcCtD
Pentoxifylline—Flushing—Levothyroxine—hypothyroidism	0.00533	0.0111	CcSEcCtD
Pentoxifylline—Abdominal distension—Liotrix—hypothyroidism	0.00531	0.011	CcSEcCtD
Pentoxifylline—ADORA2B—cerebellum—hypothyroidism	0.00527	0.0133	CbGeAlD
Pentoxifylline—PDE5A—adrenal gland—hypothyroidism	0.00523	0.0132	CbGeAlD
Pentoxifylline—PDE5A—blood—hypothyroidism	0.00523	0.0132	CbGeAlD
Pentoxifylline—Bronchospasm—Liotrix—hypothyroidism	0.00519	0.0108	CcSEcCtD
Pentoxifylline—Angina pectoris—Liotrix—hypothyroidism	0.00514	0.0107	CcSEcCtD
Pentoxifylline—Arrhythmia—Levothyroxine—hypothyroidism	0.00513	0.0107	CcSEcCtD
Pentoxifylline—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00513	0.0107	CcSEcCtD
Pentoxifylline—PDE4A—testis—hypothyroidism	0.00509	0.0128	CbGeAlD
Pentoxifylline—PDE5A—thyroid gland—hypothyroidism	0.00505	0.0127	CbGeAlD
Pentoxifylline—PDE4B—heart—hypothyroidism	0.00492	0.0124	CbGeAlD
Pentoxifylline—Tension—Dextrothyroxine—hypothyroidism	0.00491	0.0102	CcSEcCtD
Pentoxifylline—Tension—Levothyroxine—hypothyroidism	0.00491	0.0102	CcSEcCtD
Pentoxifylline—PDE5A—female gonad—hypothyroidism	0.00488	0.0123	CbGeAlD
Pentoxifylline—Nervousness—Dextrothyroxine—hypothyroidism	0.00486	0.0101	CcSEcCtD
Pentoxifylline—Nervousness—Levothyroxine—hypothyroidism	0.00486	0.0101	CcSEcCtD
Pentoxifylline—ADORA1—thyroid gland—hypothyroidism	0.00479	0.0121	CbGeAlD
Pentoxifylline—ADORA2A—testis—hypothyroidism	0.00475	0.012	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—hypothyroidism	0.0047	0.0118	CbGeAlD
Pentoxifylline—Tremor—Dextrothyroxine—hypothyroidism	0.00468	0.00973	CcSEcCtD
Pentoxifylline—Tremor—Levothyroxine—hypothyroidism	0.00468	0.00973	CcSEcCtD
Pentoxifylline—Agitation—Dextrothyroxine—hypothyroidism	0.00459	0.00954	CcSEcCtD
Pentoxifylline—Agitation—Levothyroxine—hypothyroidism	0.00459	0.00954	CcSEcCtD
Pentoxifylline—Angioedema—Levothyroxine—hypothyroidism	0.00457	0.00949	CcSEcCtD
Pentoxifylline—Angioedema—Dextrothyroxine—hypothyroidism	0.00457	0.00949	CcSEcCtD
Pentoxifylline—Sweating—Liotrix—hypothyroidism	0.00451	0.00937	CcSEcCtD
Pentoxifylline—ADORA2A—liver—hypothyroidism	0.00449	0.0113	CbGeAlD
Pentoxifylline—Palpitations—Dextrothyroxine—hypothyroidism	0.00442	0.00917	CcSEcCtD
Pentoxifylline—Palpitations—Levothyroxine—hypothyroidism	0.00442	0.00917	CcSEcCtD
Pentoxifylline—ADORA2A—cerebellum—hypothyroidism	0.00439	0.0111	CbGeAlD
Pentoxifylline—Convulsion—Dextrothyroxine—hypothyroidism	0.00433	0.009	CcSEcCtD
Pentoxifylline—Convulsion—Levothyroxine—hypothyroidism	0.00433	0.009	CcSEcCtD
Pentoxifylline—PDE5A—testis—hypothyroidism	0.00433	0.0109	CbGeAlD
Pentoxifylline—Anxiety—Levothyroxine—hypothyroidism	0.00424	0.00881	CcSEcCtD
Pentoxifylline—Anxiety—Dextrothyroxine—hypothyroidism	0.00424	0.00881	CcSEcCtD
Pentoxifylline—PDE4B—gonad—hypothyroidism	0.00421	0.0106	CbGeAlD
Pentoxifylline—Confusional state—Levothyroxine—hypothyroidism	0.00411	0.00854	CcSEcCtD
Pentoxifylline—Confusional state—Dextrothyroxine—hypothyroidism	0.00411	0.00854	CcSEcCtD
Pentoxifylline—PDE4B—pituitary gland—hypothyroidism	0.00411	0.0104	CbGeAlD
Pentoxifylline—ADORA1—testis—hypothyroidism	0.0041	0.0103	CbGeAlD
Pentoxifylline—Shock—Dextrothyroxine—hypothyroidism	0.00401	0.00834	CcSEcCtD
Pentoxifylline—Shock—Levothyroxine—hypothyroidism	0.00401	0.00834	CcSEcCtD
Pentoxifylline—PDE5A—cerebellum—hypothyroidism	0.004	0.0101	CbGeAlD
Pentoxifylline—Tachycardia—Dextrothyroxine—hypothyroidism	0.00398	0.00827	CcSEcCtD
Pentoxifylline—Tachycardia—Levothyroxine—hypothyroidism	0.00398	0.00827	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00394	0.00819	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00394	0.00819	CcSEcCtD
Pentoxifylline—Flushing—Liotrix—hypothyroidism	0.00392	0.00814	CcSEcCtD
Pentoxifylline—ADORA1—cerebellum—hypothyroidism	0.00379	0.00955	CbGeAlD
Pentoxifylline—Arrhythmia—Liotrix—hypothyroidism	0.00377	0.00784	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00372	0.00772	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00372	0.00772	CcSEcCtD
Pentoxifylline—NT5E—Differentiation Pathway—IGF1—hypothyroidism	0.00369	0.0304	CbGpPWpGaD
Pentoxifylline—Insomnia—Levothyroxine—hypothyroidism	0.00369	0.00766	CcSEcCtD
Pentoxifylline—Insomnia—Dextrothyroxine—hypothyroidism	0.00369	0.00766	CcSEcCtD
Pentoxifylline—PDE4B—adrenal gland—hypothyroidism	0.00367	0.00925	CbGeAlD
Pentoxifylline—PDE4B—blood—hypothyroidism	0.00367	0.00925	CbGeAlD
Pentoxifylline—Dyspnoea—Levothyroxine—hypothyroidism	0.00364	0.00755	CcSEcCtD
Pentoxifylline—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00364	0.00755	CcSEcCtD
Pentoxifylline—Flatulence—Liotrix—hypothyroidism	0.00362	0.00753	CcSEcCtD
Pentoxifylline—Tension—Liotrix—hypothyroidism	0.00361	0.00749	CcSEcCtD
Pentoxifylline—Dysgeusia—Liotrix—hypothyroidism	0.0036	0.00748	CcSEcCtD
Pentoxifylline—Nervousness—Liotrix—hypothyroidism	0.00357	0.00742	CcSEcCtD
Pentoxifylline—PDE4B—thyroid gland—hypothyroidism	0.00354	0.00892	CbGeAlD
Pentoxifylline—Vision blurred—Liotrix—hypothyroidism	0.00347	0.0072	CcSEcCtD
Pentoxifylline—Tremor—Liotrix—hypothyroidism	0.00345	0.00715	CcSEcCtD
Pentoxifylline—PDE4B—female gonad—hypothyroidism	0.00342	0.00862	CbGeAlD
Pentoxifylline—Agitation—Liotrix—hypothyroidism	0.00338	0.00702	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00336	0.00698	CcSEcCtD
Pentoxifylline—Feeling abnormal—Levothyroxine—hypothyroidism	0.00336	0.00698	CcSEcCtD
Pentoxifylline—Angioedema—Liotrix—hypothyroidism	0.00336	0.00698	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00334	0.00693	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00334	0.00693	CcSEcCtD
Pentoxifylline—Palpitations—Liotrix—hypothyroidism	0.00325	0.00675	CcSEcCtD
Pentoxifylline—Urticaria—Levothyroxine—hypothyroidism	0.00324	0.00673	CcSEcCtD
Pentoxifylline—Urticaria—Dextrothyroxine—hypothyroidism	0.00324	0.00673	CcSEcCtD
Pentoxifylline—Abdominal pain—Levothyroxine—hypothyroidism	0.00323	0.0067	CcSEcCtD
Pentoxifylline—Body temperature increased—Levothyroxine—hypothyroidism	0.00323	0.0067	CcSEcCtD
Pentoxifylline—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00323	0.0067	CcSEcCtD
Pentoxifylline—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00323	0.0067	CcSEcCtD
Pentoxifylline—Convulsion—Liotrix—hypothyroidism	0.00319	0.00662	CcSEcCtD
Pentoxifylline—Hypertension—Liotrix—hypothyroidism	0.00317	0.00659	CcSEcCtD
Pentoxifylline—Chest pain—Liotrix—hypothyroidism	0.00313	0.0065	CcSEcCtD
Pentoxifylline—Anxiety—Liotrix—hypothyroidism	0.00312	0.00648	CcSEcCtD
Pentoxifylline—PDE4B—testis—hypothyroidism	0.00304	0.00765	CbGeAlD
Pentoxifylline—Confusional state—Liotrix—hypothyroidism	0.00303	0.00628	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Liotrix—hypothyroidism	0.003	0.00623	CcSEcCtD
Pentoxifylline—Oedema—Liotrix—hypothyroidism	0.003	0.00623	CcSEcCtD
Pentoxifylline—Infection—Liotrix—hypothyroidism	0.00298	0.00619	CcSEcCtD
Pentoxifylline—Shock—Liotrix—hypothyroidism	0.00295	0.00613	CcSEcCtD
Pentoxifylline—Tachycardia—Liotrix—hypothyroidism	0.00293	0.00608	CcSEcCtD
Pentoxifylline—Asthenia—Dextrothyroxine—hypothyroidism	0.00293	0.00608	CcSEcCtD
Pentoxifylline—Asthenia—Levothyroxine—hypothyroidism	0.00293	0.00608	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Liotrix—hypothyroidism	0.0029	0.00603	CcSEcCtD
Pentoxifylline—Pruritus—Dextrothyroxine—hypothyroidism	0.00289	0.00599	CcSEcCtD
Pentoxifylline—Pruritus—Levothyroxine—hypothyroidism	0.00289	0.00599	CcSEcCtD
Pentoxifylline—PDE4B—liver—hypothyroidism	0.00287	0.00723	CbGeAlD
Pentoxifylline—Anorexia—Liotrix—hypothyroidism	0.00286	0.00594	CcSEcCtD
Pentoxifylline—Hypotension—Liotrix—hypothyroidism	0.0028	0.00582	CcSEcCtD
Pentoxifylline—PDE4B—cerebellum—hypothyroidism	0.0028	0.00706	CbGeAlD
Pentoxifylline—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00279	0.0058	CcSEcCtD
Pentoxifylline—Diarrhoea—Levothyroxine—hypothyroidism	0.00279	0.0058	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00273	0.00568	CcSEcCtD
Pentoxifylline—Insomnia—Liotrix—hypothyroidism	0.00271	0.00564	CcSEcCtD
Pentoxifylline—Dyspnoea—Liotrix—hypothyroidism	0.00268	0.00556	CcSEcCtD
Pentoxifylline—Decreased appetite—Liotrix—hypothyroidism	0.00261	0.00542	CcSEcCtD
Pentoxifylline—Vomiting—Dextrothyroxine—hypothyroidism	0.00259	0.00539	CcSEcCtD
Pentoxifylline—Vomiting—Levothyroxine—hypothyroidism	0.00259	0.00539	CcSEcCtD
Pentoxifylline—Rash—Dextrothyroxine—hypothyroidism	0.00257	0.00534	CcSEcCtD
Pentoxifylline—Rash—Levothyroxine—hypothyroidism	0.00257	0.00534	CcSEcCtD
Pentoxifylline—Dermatitis—Dextrothyroxine—hypothyroidism	0.00257	0.00534	CcSEcCtD
Pentoxifylline—Dermatitis—Levothyroxine—hypothyroidism	0.00257	0.00534	CcSEcCtD
Pentoxifylline—Constipation—Liotrix—hypothyroidism	0.00257	0.00533	CcSEcCtD
Pentoxifylline—Headache—Dextrothyroxine—hypothyroidism	0.00256	0.00531	CcSEcCtD
Pentoxifylline—Headache—Levothyroxine—hypothyroidism	0.00256	0.00531	CcSEcCtD
Pentoxifylline—Feeling abnormal—Liotrix—hypothyroidism	0.00247	0.00514	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Liotrix—hypothyroidism	0.00245	0.0051	CcSEcCtD
Pentoxifylline—Nausea—Levothyroxine—hypothyroidism	0.00242	0.00503	CcSEcCtD
Pentoxifylline—Nausea—Dextrothyroxine—hypothyroidism	0.00242	0.00503	CcSEcCtD
Pentoxifylline—Urticaria—Liotrix—hypothyroidism	0.00238	0.00495	CcSEcCtD
Pentoxifylline—Abdominal pain—Liotrix—hypothyroidism	0.00237	0.00493	CcSEcCtD
Pentoxifylline—Body temperature increased—Liotrix—hypothyroidism	0.00237	0.00493	CcSEcCtD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—TSHB—hypothyroidism	0.00232	0.0191	CbGpPWpGaD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—TSHR—hypothyroidism	0.00232	0.0191	CbGpPWpGaD
Pentoxifylline—CYP1A2—blood—hypothyroidism	0.00225	0.00568	CbGeAlD
Pentoxifylline—Hypersensitivity—Liotrix—hypothyroidism	0.00221	0.00459	CcSEcCtD
Pentoxifylline—CYP1A2—thyroid gland—hypothyroidism	0.00218	0.00548	CbGeAlD
Pentoxifylline—Asthenia—Liotrix—hypothyroidism	0.00215	0.00447	CcSEcCtD
Pentoxifylline—Pruritus—Liotrix—hypothyroidism	0.00212	0.00441	CcSEcCtD
Pentoxifylline—PDE4A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00211	0.0173	CbGpPWpGaD
Pentoxifylline—PDE4A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00211	0.0173	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00208	0.0171	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Liotrix—hypothyroidism	0.00205	0.00426	CcSEcCtD
Pentoxifylline—Dizziness—Liotrix—hypothyroidism	0.00198	0.00412	CcSEcCtD
Pentoxifylline—PDE4B—G alpha (s) signalling events—TSHB—hypothyroidism	0.00195	0.016	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—TSHR—hypothyroidism	0.00195	0.016	CbGpPWpGaD
Pentoxifylline—Vomiting—Liotrix—hypothyroidism	0.00191	0.00396	CcSEcCtD
Pentoxifylline—Rash—Liotrix—hypothyroidism	0.00189	0.00393	CcSEcCtD
Pentoxifylline—Dermatitis—Liotrix—hypothyroidism	0.00189	0.00393	CcSEcCtD
Pentoxifylline—Headache—Liotrix—hypothyroidism	0.00188	0.0039	CcSEcCtD
Pentoxifylline—Nausea—Liotrix—hypothyroidism	0.00178	0.0037	CcSEcCtD
Pentoxifylline—CYP1A2—liver—hypothyroidism	0.00176	0.00444	CbGeAlD
Pentoxifylline—NT5E—Metabolism—IYD—hypothyroidism	0.00163	0.0134	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—NKX2-1—hypothyroidism	0.0016	0.0132	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00152	0.0125	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00152	0.0125	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ATP5O—hypothyroidism	0.00139	0.0114	CbGpPWpGaD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—AVP—hypothyroidism	0.00137	0.0112	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—TPO—hypothyroidism	0.0013	0.0107	CbGpPWpGaD
Pentoxifylline—PDE4A—G alpha (s) signalling events—AVP—hypothyroidism	0.00124	0.0102	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00124	0.0102	CbGpPWpGaD
Pentoxifylline—PDE4A—Opioid Signalling—POMC—hypothyroidism	0.00116	0.00954	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—AVP—hypothyroidism	0.00115	0.00944	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00111	0.00909	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00111	0.00909	CbGpPWpGaD
Pentoxifylline—PDE4B—Opioid Signalling—POMC—hypothyroidism	0.00107	0.00882	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00105	0.00867	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—SH2B3—hypothyroidism	0.00101	0.00827	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—TRH—hypothyroidism	0.000944	0.00777	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00094	0.00773	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00094	0.00773	CbGpPWpGaD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—POMC—hypothyroidism	0.000908	0.00747	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—AVP—hypothyroidism	0.000897	0.00738	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—TSHB—hypothyroidism	0.000842	0.00692	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—TSHR—hypothyroidism	0.000842	0.00692	CbGpPWpGaD
Pentoxifylline—PDE4A—G alpha (s) signalling events—POMC—hypothyroidism	0.000825	0.00678	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000814	0.0067	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TRH—hypothyroidism	0.000803	0.00661	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—AVP—hypothyroidism	0.000789	0.00649	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—POMC—hypothyroidism	0.000763	0.00628	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000726	0.00597	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000726	0.00597	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TSHB—hypothyroidism	0.000716	0.00589	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TSHR—hypothyroidism	0.000716	0.00589	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—VAV3—hypothyroidism	0.00069	0.00568	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000651	0.00536	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TRH—hypothyroidism	0.00062	0.0051	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—AVP—hypothyroidism	0.00061	0.00501	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—TSHB—hypothyroidism	0.000604	0.00496	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—POMC—hypothyroidism	0.000596	0.0049	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000554	0.00456	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TSHB—hypothyroidism	0.000553	0.00455	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TSHR—hypothyroidism	0.000553	0.00455	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3C2A—hypothyroidism	0.000538	0.00442	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TRH—hypothyroidism	0.000534	0.00439	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—AVP—hypothyroidism	0.000496	0.00408	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TRH—hypothyroidism	0.000485	0.00399	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TRH—hypothyroidism	0.000485	0.00399	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—VAV3—hypothyroidism	0.000477	0.00392	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000476	0.00391	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000476	0.00391	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—POMC—hypothyroidism	0.000463	0.00381	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TRH—hypothyroidism	0.000454	0.00373	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—SLC5A5—hypothyroidism	0.000452	0.00372	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TRH—hypothyroidism	0.000448	0.00369	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TRH—hypothyroidism	0.00044	0.00362	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000433	0.00356	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TSHB—hypothyroidism	0.000432	0.00355	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TSHR—hypothyroidism	0.000432	0.00355	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TSHB—hypothyroidism	0.000432	0.00355	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TSHR—hypothyroidism	0.000432	0.00355	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000428	0.00352	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—IGF1—hypothyroidism	0.000425	0.0035	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—AVP—hypothyroidism	0.000422	0.00347	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TRH—hypothyroidism	0.000412	0.00339	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TRH—hypothyroidism	0.000407	0.00335	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TSHB—hypothyroidism	0.000404	0.00333	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TSHR—hypothyroidism	0.000404	0.00333	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TSHB—hypothyroidism	0.0004	0.00329	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TSHR—hypothyroidism	0.0004	0.00329	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TSHB—hypothyroidism	0.000392	0.00323	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TSHR—hypothyroidism	0.000392	0.00323	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000368	0.00303	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TSHB—hypothyroidism	0.000367	0.00302	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TSHR—hypothyroidism	0.000367	0.00302	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TSHB—hypothyroidism	0.000363	0.00299	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TSHR—hypothyroidism	0.000363	0.00299	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TRH—hypothyroidism	0.00035	0.00288	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CLTC—hypothyroidism	0.000331	0.00272	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—POMC—hypothyroidism	0.00033	0.00271	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—AVP—hypothyroidism	0.000326	0.00268	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TRH—hypothyroidism	0.000318	0.00262	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000312	0.00257	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000312	0.00257	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CLTC—hypothyroidism	0.000301	0.00247	CbGpPWpGaD
Pentoxifylline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000296	0.00243	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000291	0.00239	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TRH—hypothyroidism	0.000286	0.00235	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000284	0.00234	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TSHB—hypothyroidism	0.000284	0.00233	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TSHR—hypothyroidism	0.000284	0.00233	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CLTC—hypothyroidism	0.000282	0.00232	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AVP—hypothyroidism	0.00028	0.00231	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—POMC—hypothyroidism	0.00028	0.00231	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CLTC—hypothyroidism	0.000278	0.00229	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—VAV3—hypothyroidism	0.000264	0.00217	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—VAV3—hypothyroidism	0.000264	0.00217	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TRH—hypothyroidism	0.00026	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TSHR—hypothyroidism	0.000255	0.0021	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TSHB—hypothyroidism	0.000255	0.0021	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AVP—hypothyroidism	0.000255	0.00209	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AVP—hypothyroidism	0.000255	0.00209	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—VAV3—hypothyroidism	0.000247	0.00204	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—VAV3—hypothyroidism	0.000244	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TRH—hypothyroidism	0.000243	0.002	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TRH—hypothyroidism	0.000241	0.00198	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—VAV3—hypothyroidism	0.00024	0.00197	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00024	0.00197	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AVP—hypothyroidism	0.000238	0.00196	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—POMC—hypothyroidism	0.000236	0.00194	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AVP—hypothyroidism	0.000236	0.00194	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TSHR—hypothyroidism	0.000232	0.00191	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TSHB—hypothyroidism	0.000232	0.00191	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AVP—hypothyroidism	0.000231	0.0019	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SH2B3—hypothyroidism	0.000227	0.00187	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—VAV3—hypothyroidism	0.000225	0.00185	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—VAV3—hypothyroidism	0.000222	0.00183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CLTC—hypothyroidism	0.000217	0.00179	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSHB—hypothyroidism	0.000217	0.00178	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSHR—hypothyroidism	0.000217	0.00178	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AVP—hypothyroidism	0.000216	0.00178	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—POMC—hypothyroidism	0.000216	0.00178	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSHB—hypothyroidism	0.000214	0.00176	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSHR—hypothyroidism	0.000214	0.00176	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AVP—hypothyroidism	0.000214	0.00176	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SH2B3—hypothyroidism	0.000207	0.0017	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SH2B3—hypothyroidism	0.000193	0.00159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SH2B3—hypothyroidism	0.000191	0.00157	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000191	0.00157	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TRH—hypothyroidism	0.000188	0.00155	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—POMC—hypothyroidism	0.000186	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AVP—hypothyroidism	0.000184	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—VAV3—hypothyroidism	0.000173	0.00143	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—POMC—hypothyroidism	0.000169	0.00139	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—POMC—hypothyroidism	0.000169	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRL—hypothyroidism	0.000169	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSHR—hypothyroidism	0.000168	0.00138	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSHB—hypothyroidism	0.000168	0.00138	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AVP—hypothyroidism	0.000167	0.00137	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—POMC—hypothyroidism	0.000158	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—POMC—hypothyroidism	0.000157	0.00129	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VAV3—hypothyroidism	0.000156	0.00128	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—POMC—hypothyroidism	0.000154	0.00126	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRL—hypothyroidism	0.000153	0.00126	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AVP—hypothyroidism	0.00015	0.00124	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—IYD—hypothyroidism	0.00015	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SH2B3—hypothyroidism	0.000149	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—hypothyroidism	0.000144	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRL—hypothyroidism	0.000143	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—hypothyroidism	0.000142	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRL—hypothyroidism	0.000142	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VAV3—hypothyroidism	0.000142	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AVP—hypothyroidism	0.000137	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VAV3—hypothyroidism	0.000133	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VAV3—hypothyroidism	0.000131	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AVP—hypothyroidism	0.000128	0.00105	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ATP5O—hypothyroidism	0.000128	0.00105	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—hypothyroidism	0.000127	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AVP—hypothyroidism	0.000126	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—hypothyroidism	0.000122	0.00101	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TPO—hypothyroidism	0.00012	0.000988	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000111	0.000915	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—hypothyroidism	0.000111	0.000914	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRL—hypothyroidism	0.000111	0.000911	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VAV3—hypothyroidism	0.000102	0.000843	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—hypothyroidism	9.99e-05	0.000822	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AVP—hypothyroidism	9.87e-05	0.000812	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—hypothyroidism	9.61e-05	0.000791	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—hypothyroidism	9.08e-05	0.000746	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—hypothyroidism	8.73e-05	0.000718	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—hypothyroidism	8.5e-05	0.000699	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—hypothyroidism	8.4e-05	0.000691	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—hypothyroidism	8.17e-05	0.000672	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—hypothyroidism	8.08e-05	0.000664	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—hypothyroidism	6.56e-05	0.00054	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—hypothyroidism	6.31e-05	0.000519	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TSHB—hypothyroidism	5.56e-05	0.000457	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	4.96e-05	0.000408	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.89e-05	0.000402	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC5A5—hypothyroidism	4.16e-05	0.000342	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—hypothyroidism	2.18e-05	0.000179	CbGpPWpGaD
